Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Combining bromelain with finasteride improves hair regrowth and reduces inflammation in alopecia.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

EGFR inhibitors can cause unusual localized hair growth.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Sorafenib may cause hair loss in a way similar to alopecia areata.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.